Risk and Validation Engineer-Operations Engineering
About the role:
We are looking for a Risk and Validation Engineer to join our Operations Engineering team and play a key role in ensuring the quality, compliance, and reliability of our manufacturing processes and equipment within a global medical device environment.
In this role, you will lead and support validation and risk management activities across internal and external operations, helping ensure compliance with FDA and ISO requirements while driving continuous improvement initiatives. You will be responsible for managing validation programs, maintaining risk management documentation, supporting audits, and collaborating closely with cross-functional teams to ensure high standards across systems, products, and processes.
This position requires a strong combination of technical expertise, analytical thinking, organizational skills, and the ability to manage multiple priorities in a fast-paced and highly regulated environment.
Success in this role means becoming a trusted subject matter expert for validation and risk-related activities, driving projects forward with a high level of ownership, maintaining strong collaboration with internal and external stakeholders, and ensuring compliance and operational excellence across validation processes.
What you will do:
What you will bring:
Who you are:
ABOUT NOVOCURE:
Novocure is a company with a powerful mission: to extend the lives of people living with some of the most aggressive forms of cancer. Here, your work will have a direct impact on patients and those who care about them. Join a team of passionate, collaborative people who support each other, challenge one another, and innovate together. Here, you’ll connect, grow, and make a real difference. We’re a company with the drive of a startup and the strength that comes with 25 years of success.
Novocure operates at a rare crossroad, where advanced medical technology converges with cutting-edge biotechnology. We are the only company to develop and commercialize Tumor Treating Fields (TTFields), a proprietary, groundbreaking therapy designed to disrupt cancer cell division. With us you will find a unique combination of laboratory research work alongside engineering development of advanced technologies. This fusion of disciplines positions us as true pioneers in oncology innovation, leading a new frontier in the treatment of aggressive cancers.
Our patient-forward values
– innovation
– focus
– drive
– courage
– trust
– empathy

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.